Want to see SE:SECT.B full AI Analyst Report?
Top Page
Sectra AB Class B
(SECT.B)
Select Model
Select Model
Rating:74Outperform
Price Target:
kr325.00
▲(17.67% Upside)
Action:Reiterated
Date:09/07/26
The score is driven primarily by strong financial quality (profitability and a very low-leverage balance sheet) and supportive uptrend/momentum signals. The main constraint is valuation: a very high P/E and low dividend yield reduce the risk-adjusted attractiveness despite solid fundamentals.
Positive Factors
Strong profitability
Sectra’s strong net and operating margins indicate effective cost control and attractive economics in its medical IT and cybersecurity activities. Sustained profitability can support investment in product development, customer service, and market expansion while providing resilience across business cycles.
Negative Factors
Slowing revenue growth
Although Sectra continues to grow, the slower top-line trajectory points to a more mature growth profile and may limit the pace at which operating leverage and earnings can expand. Sustaining attractive long-term returns will depend more heavily on retention, product development, and execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong profitability
Sectra’s strong net and operating margins indicate effective cost control and attractive economics in its medical IT and cybersecurity activities. Sustained profitability can support investment in product development, customer service, and market expansion while providing resilience across business cycles.
Read all positive factors
Sectra AB Class B (SECT.B) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr56.62B
Dividend Yield0.45%
Average Volume (3M)220.61K
Price to Earnings (P/E)88.7
Beta (1Y)0.51
Revenue Growth13.94%
EPS Growth5.70%
CountrySE
Employees1,403
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)3.27
Shares Outstanding182,017,440
10 Day Avg. Volume236,689
30 Day Avg. Volume220,614
Financial Highlights & Ratios
PEG Ratio254.33
Price to Book (P/B)22.99
Price to Sales (P/S)13.88
P/FCF Ratio48.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)3.85
Revenue Forecast (FY)kr4.16B
Sectra AB Class B Business Overview & Revenue Model
Company Description
Sectra AB (publ), a Swedish company established in Linköping in 1957, specializes in providing advanced information technology solutions for both the medical and cybersecurity fields. Its services are predominantly offered across Europe, including...
How the Company Makes Money
Sectra primarily makes money by selling software and related services in two main business areas: medical imaging IT and secure communications.
In medical imaging IT, revenue is generated from licensing its imaging software platforms (e.g., PACS ...
Sectra AB Class B Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.74B | 3.54B | 3.24B | 2.96B | 2.35B | 1.95B |
| Gross Profit | 924.81M | 714.42M | 543.41M | 557.55M | 488.91M | 1.71B |
| EBITDA | 843.14M | 733.07M | 795.35M | 615.06M | 538.55M | 477.28M |
| Net Income | 618.99M | 563.78M | 563.37M | 428.39M | 374.96M | 314.79M |
Balance Sheet | ||||||
| Total Assets | 4.49B | 4.47B | 3.76B | 3.21B | 2.74B | 2.19B |
| Cash, Cash Equivalents and Short-Term Investments | 1.75B | 1.81B | 1.34B | 804.64M | 945.24M | 808.77M |
| Total Debt | 127.64M | 76.48M | 87.46M | 31.79M | 82.26M | 62.62M |
| Total Liabilities | 2.17B | 2.34B | 1.84B | 1.64B | 1.44B | 1.11B |
| Stockholders Equity | 2.32B | 2.14B | 1.92B | 1.57B | 1.30B | 1.08B |
Cash Flow | ||||||
| Free Cash Flow | 848.87M | 1.01B | 812.37M | 75.58M | 347.70M | 542.55M |
| Operating Cash Flow | 981.92M | 1.10B | 922.36M | 326.33M | 440.49M | 616.92M |
| Investing Cash Flow | -230.54M | -207.46M | -113.86M | -130.74M | -212.79M | -68.35M |
| Financing Cash Flow | -430.11M | -428.43M | -251.88M | -222.20M | -219.29M | -198.75M |
Sectra AB Class B Technical Analysis
Positive
276.20
Price Trends
281.04
Positive
280.31
Positive
253.82
Positive
Market Momentum
1.86
Positive
54.31
Neutral
65.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SECT.B, the sentiment is Positive. The current price of 276.2 is below the 20-day moving average (MA) of 287.77, below the 50-day MA of 281.04, and above the 200-day MA of 253.82, indicating a bullish trend. The MACD of 1.86 indicates Positive momentum. The RSI at 54.31 is Neutral, neither overbought nor oversold. The STOCH value of 65.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:SECT.B.
Sectra AB Class B Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | kr4.11B | 31.16 | 14.59% | 1.63% | -1.64% | -14.61% | |
75 Outperform | kr67.33B | 25.07 | 8.88% | 1.93% | -3.56% | 79.60% | |
74 Outperform | kr56.62B | 88.75 | 30.26% | 0.45% | 13.94% | 5.70% | |
70 Outperform | kr7.04B | 76.01 | 4.13% | ― | 8.79% | -20.48% | |
60 Neutral | kr416.26M | -86.40 | -3.61% | ― | 15.87% | 92.43% | |
57 Neutral | kr12.58B | -2.49 | -53.29% | 1.20% | -4.21% | -1194.93% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
SE:SECT.B
Sectra AB Class B
290.20
-12.58
-4.16%
SE:GETI.B
Getinge
246.40
38.12
18.30%
SE:VITR
Vitrolife AB
91.80
-48.46
-34.55%
SE:CEVI
CellaVision AB
168.60
-11.59
-6.43%
SE:XVIVO
Xvivo Perfusion AB
213.60
38.40
21.92%
SE:MNTC
Mentice AB
14.80
4.15
38.97%
Sectra AB Class B Corporate Events
Sectra Breaks SEK 1 Billion Mark in Cloud Recurring Revenue
Sep 4, 2026
Sectra reported that its rolling 12-month cloud recurring revenue passed SEK 1 billion for the first time, driven by strong historical order bookings and long-term investments in scalable cloud services. The company’s recurring revenue now m...
Sectra Calls 2026 AGM and Expands Options for Shareholder Voting
Aug 6, 2026
Sectra AB has called its shareholders to the Annual General Meeting on September 8, 2026, in Linköping, Sweden, where attendees will also have the opportunity to visit the company’s offices and view its products. The notice outlines det...
Sectra links annual and sustainability reporting to mission of a safer, healthier society
Jul 8, 2026
Sectra AB Class B has released its Annual Report and Sustainability Report for 2025/2026, highlighting its dual focus on healthcare IT and cybersecurity as central to building a healthier and safer society. The company underscores how its technolo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.